89415-54-3 Usage
General Description
5-Bromo-2-N-methylpyridine-2,3-diamine is a chemical compound with the molecular formula C7H9BrN4. It is a derivative of pyridine and is commonly used in organic synthesis and pharmaceutical research. 5-BroMo-2-N-Methylpyridine-2,3-diaMine contains a bromine atom, a methyl group, and two amine groups. It is often used as a building block in the synthesis of pharmaceutical drugs and other organic compounds. Additionally, it has applications in the development of new materials and as a reagent in chemical reactions. 5-Bromo-2-N-methylpyridine-2,3-diamine is a valuable compound in the field of organic chemistry due to its versatility and ability to participate in a wide range of chemical reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 89415-54-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,4,1 and 5 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 89415-54:
(7*8)+(6*9)+(5*4)+(4*1)+(3*5)+(2*5)+(1*4)=163
163 % 10 = 3
So 89415-54-3 is a valid CAS Registry Number.
89415-54-3Relevant articles and documents
Quinazolinone Compound and Application Thereof
-
, (2020/11/27)
The present invention relates to a series of quinazolinone compounds and applications thereof as PI3Kα inhibitors. In particular, the present invention relates to a compound shown in formula (I) and a tautomer or pharmaceutically acceptable salt thereof.
SUBSTITUTED 1H-IMIDAZO[4,5-B]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS
-
, (2018/04/23)
Substituted 1 H-imidazo[4,5-b]pyridin-2(3H)-ones as NR2B receptor ligands. Such compounds may be used in NR2B receptor modulation and in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by NR2B receptor activity.
AMINOQUINOLINE DERIVATIVES AS ANTIVIRAL AGENTS
-
, (2012/04/04)
Provided are compounds of Formula (I) and Formula (II) and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the Flaviviridae family of viruses such as hepatitis C virus (HCV).